Diabetes & NASH Discovery | InSphero

Advanced 3D models for metabolic disease research and drug efficacy testing

3D InSight™ Platforms for Diabetes and Liver Disease Discovery provide comprehensive 3D in vitro solutions for investigating metabolic disease pathophysiology and screening new drugs and therapies for type 1 and type 2 diabetes and the full progression of non-alcoholic fatty liver disease (NAFLD), from steatosis to non-alcoholic steatohepatitis (NASH) and fibrosis. Our precisely engineered, disease-tunable 3D models include islet and liver models based on our innovative 3D cell-based technology that closely mimic healthy and diseased human biology.

Find out how InSphero platforms for metabolic disease discovery

can accelerate safety and efficacy testing of your drug.

Get Started